HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.

Abstract
Although the usefulness of high-dose chemotherapy with peripheral blood stem cell transplantation for advanced germ cell tumor is still under evaluation in phase III randomized controlled studies, this approach is currently used as one treatment option for relapsed or advanced male germ cell tumor. Clinical outcomes of high-dose chemotherapy for a single institute from Japan are presented herein. We administered 63 courses of high-dose ifosfamide, carboplatin and etoposide chemotherapy (1250 mg/m carboplatin; 1500 mg/m etoposide; 7.5 g/m ifosfamide) to 34 men with germ cell tumors. Of these, 27 patients underwent high-dose ifosfamide, carboplatin and etoposide as first-line therapy after 2-3 courses of conventional bleomycin, etoposide and cisplatin chemotherapy, and seven patients underwent high-dose ifosfamide, carboplatin and etoposide for relapsed germ cell tumor. Peripheral blood stem cells were harvested during previous chemotherapy and sufficient CD34 cells were harvested for transplantation. Although all patients experienced grade 4 hemotoxicity, leukocyte counts recovered to above 1000/mul within 8-11 days after peripheral blood stem cell transplantation. No treatment-related deaths occurred. After a mean follow-up of 45 months (range 12-118 months), 23 of 34 patients (67.6%) remained disease-free. High-dose ifosfamide, carboplatin and etoposide could be performed safely, and could offer an effective means of treating advanced or refractory germ cell tumors in men.
AuthorsIsao Hara, Hideaki Miyake, Yuji Yamada, Kazuki Yamanaka, Junya Furukawa, Masafumi Kumano, Atsuhi Takenaka, Masato Fujisawa
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 17 Issue 9 Pg. 1057-66 (Oct 2006) ISSN: 0959-4973 [Print] England
PMID17001179 (Publication Type: Journal Article)
Chemical References
  • Bleomycin
  • Etoposide
  • Carboplatin
  • Cisplatin
  • Ifosfamide
Topics
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects, therapeutic use)
  • Bleomycin (administration & dosage)
  • Carboplatin (administration & dosage)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Etoposide (administration & dosage)
  • Germinoma (therapy)
  • Humans
  • Ifosfamide (administration & dosage)
  • Male
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal (therapy)
  • Peripheral Blood Stem Cell Transplantation
  • Testicular Neoplasms (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: